Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer

Moolenaar, 1995, Lysophosphatidic acid, a multifunctional phospholipid messenger, J Biol Chem, 270, 12949, 10.1074/jbc.270.22.12949

Moolenaar, 1999, Bioactive lysophospholipids and their G protein-coupled receptors, Exp Cell Res, 253, 230, 10.1006/excr.1999.4702

Goetzl, 1998, Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate, FASEB J, 12, 1589, 10.1096/fasebj.12.15.1589

Mills, 2003, The emerging role of lysophosphatidic acid in cancer, Nat Rev Cancer, 3, 582, 10.1038/nrc1143

Xu, 1998, Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers, JAMA, 280, 719, 10.1001/jama.280.8.719

Erickson, 2001, Lysophosphatidic acid and ovarian cancer: a paradigm for tumorigenesis and patient management, Prostaglandins, 64, 63, 10.1016/S0090-6980(01)00100-9

Baker, 2002, Plasma lysophosphatidic acid concentration and ovarian cancer, JAMA, 287, 3081, 10.1001/jama.287.23.3081

Xu, 1995, Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients, Clin Cancer Res, 1, 1223

Goetzl, 1999, Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer, Cancer Res, 59, 5370

Hu, 2001, Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells, J Natl Cancer Inst, 93, 762, 10.1093/jnci/93.10.762

Fishman, 2001, Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells, Cancer Res, 61, 3194

Schwartz, 2001, Lysophospholipids increase interleukin-8 expression in ovarian cancer cells, Gynecol Oncol, 81, 291, 10.1006/gyno.2001.6124

Mills, 2002, Critical role of lysophospholipids in the pathophysiology, diagnosis, and management of ovarian cancer, Cancer Treat Res, 107, 259

An, 1998, Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid, J Biol Chem, 273, 7906, 10.1074/jbc.273.14.7906

Bandoh, 1999, Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid, J Biol Chem, 274, 27776, 10.1074/jbc.274.39.27776

Contos, 2000, Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior, Proc Natl Acad Sci USA, 97, 13384, 10.1073/pnas.97.24.13384

Contos, 2002, Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2), Mol Cell Biol, 22, 6921, 10.1128/MCB.22.19.6921-6929.2002

Fang, 2000, Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer, Ann NY Acad Sci, 905, 188, 10.1111/j.1749-6632.2000.tb06550.x

Schulte, 2001, Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer, Int J Cancer, 92, 249, 10.1002/1097-0215(200102)9999:9999<::AID-IJC1166>3.0.CO;2-D

Fang, 2002, Lysophosphatidic acid is a bioactive mediator in ovarian cancer, Biochim Biophys Acta, 1582, 257, 10.1016/S1388-1981(02)00179-8

Fujita, 2003, Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer, Cancer Lett, 192, 161, 10.1016/S0304-3835(02)00713-9

Shida, 2003, Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1, Cancer Res, 63, 1706

Aoki, 2002, Serum lysophosphatidic acid is produced through diverse phospholipase pathways, J Biol Chem, 277, 48737, 10.1074/jbc.M206812200

Fischer, 2001, Short-chain phosphatidates are subtype-selective antagonists of lysophosphatidic acid receptors, Mol Pharmacol, 60, 776

Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction, Anal Biochem, 162, 156, 10.1016/0003-2697(87)90021-2

Gschwind, 2002, Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation, Cancer Res, 62, 6329

Daub, 1996, Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors, Nature, 379, 557, 10.1038/379557a0

Prenzel, 1999, EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF, Nature, 402, 884, 10.1038/47260

Fischer, 2003, EGFR signal transactivation in cancer cells, Biochem Soc Trans, 31, 1203, 10.1042/bst0311203

Kue, 2002, Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells, Int J Cancer, 102, 572, 10.1002/ijc.10734

Furui, 1999, Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner, Clin Cancer Res, 5, 4308

Huang, 2002, Lysophospholipid mediators of immunity and neoplasia, Biochim Biophys Acta, 1582, 161, 10.1016/S1388-1981(02)00151-8

Goetzl, 1999, Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax, J Immunol, 162, 2049, 10.4049/jimmunol.162.4.2049

Swarthout, 2000, Lysophosphatidic acid: receptors, signaling and survival, Cell Mol Life Sci, 57, 1978, 10.1007/PL00000678

Deng, 2002, Lysophosphatidic acid protects and rescues intestinal epithelial cells from radiation- and chemotherapy-induced apoptosis, Gastroenterology, 123, 206, 10.1053/gast.2002.34209

Goetzl, 2000, Cutting edge: differential constitutive expression of functional receptors for lysophosphatidic acid by human blood lymphocytes, J Immunol, 164, 4996, 10.4049/jimmunol.164.10.4996

Zheng, 2001, Lysophosphatidic acid receptor-selective effects on Jurkat T cell migration through a Matrigel model basement membrane, J Immunol, 166, 2317, 10.4049/jimmunol.166.4.2317

Vogelstein, 1988, Genetic alterations during colorectal-tumor development, N Engl J Med, 319, 525, 10.1056/NEJM198809013190901

Haydon, 2002, Emerging pathways in colorectal-cancer development, Lancet Oncol, 3, 83, 10.1016/S1470-2045(02)00649-6

Lamlum, 2000, APC mutations are sufficient for the growth of early colorectal adenomas, Proc Natl Acad Sci USA, 97, 2225, 10.1073/pnas.040564697

Moser, 1990, A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse, Science, 247, 322, 10.1126/science.2296722

Moser, 1992, The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system, J Cell Biol, 116, 1517, 10.1083/jcb.116.6.1517

Dietrich, 1993, Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse, Cell, 75, 631, 10.1016/0092-8674(93)90484-8

Giardiello, 1994, Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation, Gastroenterology, 106, 1542, 10.1016/0016-5085(94)90408-1

Gould, 1996, Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice, Genetics, 144, 1769, 10.1093/genetics/144.4.1769

Gould, 1996, Genetic evaluation of candidate genes for the Mom1 modifier of intestinal neoplasia in mice, Genetics, 144, 1777, 10.1093/genetics/144.4.1777

MacPhee, 1995, The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia, Cell, 81, 957, 10.1016/0092-8674(95)90015-2

Watson, 1997, Lipid metabolism and APC: implications for colorectal cancer prevention, Lancet, 349, 444, 10.1016/S0140-6736(97)22007-6

DuBois, 1996, Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention, Gastroenterol Clin North Am, 25, 773, 10.1016/S0889-8553(05)70274-0

Eberhart, 1994, Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology, 107, 1183, 10.1016/0016-5085(94)90246-1

Hla, 2001, Lysophospholipids—receptor revelations, Science, 294, 1875, 10.1126/science.1065323